RankingsPricing
  1. US-listed companies
  2. ACADIA PHARMACEUTICALS INC
  3. Financials
  4. Return on equity (%)

ACADIA PHARMACEUTICALS INC【ACAD】

Market cap
$4.5B
P/E ratio
SummaryFinancials
Period EndReturn on equity (%) (Million USD)YoY (%)
Dec 31, 202438.9-364.02%
Dec 31, 2023-14.7-67.90%
Dec 31, 2022-45.9+59.62%
Dec 31, 2021-28.7-32.31%
Dec 31, 2020-42.5+6.36%
Dec 31, 2019-39.9-33.69%
Dec 31, 2018-60.2-11.18%
Dec 31, 2017-67.8-10.29%
Dec 31, 2016-75.6+17.03%
Dec 31, 2015-64.6+71.66%
Dec 31, 2014-37.6+32.42%
Dec 31, 2013-28.4-26.19%
Dec 31, 2012-38.5

Income Statement

RevenueRevenue growth (%)Cost of revenueGross profitGross margin (%)Research & developmentSelling, general & administrativeOperating margin (%)Operating income Operating expenses Income before tax Pretax margin (%)Provision for income taxesEffective tax rate (%)Net income Net income margin (%)Earnings per shareDiluted EPSAdjusted EPSDividend payout ratio (%)Dividend per shareAdjusted DPSEBITDAEBITDA margin (%)

Balance Sheet

Cash and cash equivalents Marketable securities, current Total cash & short-term investmentsAccounts receivable, netInventoriesTotal current assetsProperty, plant and equipment, netMarketable securities, non-current Total non-current assetsTotal assets Accounts payableShort-term debtLong-term debt, current Total current liabilitiesLong-term debt, non-current Total non-current liabilitiesTotal liabilities Common stock and paid-in capital Retained earningsStockholders' equityTotal debtNet debtD/E ratio (%)Working capital

Cash Flow

Depreciation & amortizationStock-based compensationCash from operations Capital expendituresCash from investing Payments for dividends Repurchases of common stockProceeds from issuance of term debt, netRepayments of term debtCash from financing Free cash flowFCF margin (%)